Back to All Events

Webinar – Retinoblastoma & Chemotherapy-Induced AML Risk

Are children with retinoblastoma at higher risk of chemotherapy-induced acute myeloblastic leukemia?

The Pediatric Cancer Center Barcelona (PCCB) continues its webinar series with an in-depth look at this important—and often controversial—question. Dr. David H. Abramson and colleagues will share the latest data, highlight knowledge gaps, and invite your questions in an interactive discussion.

Session details

  • Date: Friday, May 23 2025

  • Time: 2:00 PM Eastern (UTC-4) · 8:00 PM CEST

  • Format: 45-minute presentations + live Q&A

  • Cost: Free

How to join

Click below to register and receive your Zoom access:

Register / Join on Zoom
Meeting ID: 878 0212 6136 · Passcode: 090686

Whether you treat retinoblastoma directly or study pediatric oncology more broadly, your insight is welcome—bring your questions and join the conversation!

Hosted by: Guillermo Chantada

Previous
Previous
May 23

Strategies to Improve Retinoblastoma Outcomes in Low Resource Settings

Next
Next
June 7

Ohio Ocular Oncology Symposium